CanSino Biologics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,329	2,023	2,822	3,465	5,645
Short-Term Investments	326.32	-	-	-	275.2
Trading Asset Securities	987.97	1,182	1,308	2,482	1,862
Cash & Short-Term Investments	2,644	3,204	4,130	5,947	7,783
Cash Growth	-17.50%	-22.41%	-30.55%	-23.59%	52.19%
Accounts Receivable	782.88	737.62	636.88	855.49	157.93
Other Receivables	43.41	44.79	3.98	0.54	19.15
Receivables	862.62	818.73	640.87	856.03	177.08
Inventory	347.85	283.41	352.85	677.78	875.62
Prepaid Expenses	-	-	0.25	-	-
Other Current Assets	-15.38	-24.03	57	249.59	454.49
Total Current Assets	3,839	4,282	5,181	7,730	9,290
Property, Plant & Equipment	2,611	2,641	3,013	3,069	2,218
Long-Term Investments	162.09	483.71	446.56	50.12	45.31
Other Intangible Assets	188.75	115.49	144.15	220.92	172.12
Long-Term Deferred Tax Assets	211.55	205.39	207.86	196.41	-
Long-Term Deferred Charges	137.93	172.21	88.4	51.95	26.19
Other Long-Term Assets	27.34	57.99	237.53	150.37	122.42
Total Assets	7,178	7,958	9,319	11,469	11,874
Accounts Payable	50.44	62.47	103.97	253.12	842.57
Accrued Expenses	456.29	400.08	454.55	407.25	362.44
Short-Term Debt	73.22	377.35	883.97	1,530	990.68
Current Portion of Long-Term Debt	245.31	514.82	509.17	45.77	90.11
Current Portion of Leases	5.43	9.99	64.63	48.76	31.18
Current Income Taxes Payable	5.12	4.66	0.54	3	29.14
Current Unearned Revenue	18.23	14.69	3.57	1.48	193.22
Other Current Liabilities	190.98	302.68	544.9	635.52	322.08
Total Current Liabilities	1,045	1,687	2,565	2,925	2,861
Long-Term Debt	956.95	1,099	1,066	878.01	40
Long-Term Leases	7.62	12.68	175.18	198.29	222.85
Long-Term Unearned Revenue	214.38	250.3	216.72	222.35	201.48
Long-Term Deferred Tax Liabilities	-	-	-	-	0.56
Other Long-Term Liabilities	-	-	8.49	-	-
Total Liabilities	2,224	3,048	4,031	4,223	3,326
Common Stock	247.04	247.45	247.45	247.45	247.45
Additional Paid-In Capital	5,165	6,577	6,574	6,608	6,598
Retained Earnings	-459.08	-1,819	-1,440	42.71	1,150
Treasury Stock	-	-95.62	-106.17	-150.17	-
Comprehensive Income & Other	0.19	0.22	-0.18	0.12	-
Total Common Equity	4,954	4,910	5,275	6,748	7,995
Minority Interest	-	-	12.81	497.51	552.84
Shareholders' Equity	4,954	4,910	5,287	7,246	8,548
Total Liabilities & Equity	7,178	7,958	9,319	11,469	11,874
Total Debt	1,289	2,013	2,699	2,701	1,375
Net Cash (Debt)	1,355	1,191	1,431	3,246	6,408
Net Cash Growth	13.79%	-16.79%	-55.91%	-49.34%	28.90%
Net Cash Per Share	5.35	4.81	5.80	13.14	25.91
Filing Date Shares Outstanding	247.04	249.18	247.04	246.77	247.45
Total Common Shares Outstanding	247.04	249.18	247.04	246.77	247.45
Working Capital	2,794	2,596	2,616	4,805	6,428
Book Value Per Share	20.05	19.70	21.35	27.35	32.31
Tangible Book Value	4,765	4,794	5,130	6,527	7,823
Tangible Book Value Per Share	19.29	19.24	20.77	26.45	31.61
Buildings	1,294	1,025	978.89	729.03	724.68
Machinery	878.09	773.61	1,189	1,050	537.75
Construction In Progress	1,021	1,268	1,114	1,342	820.8

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.